Bette  Caan  to  Biomarkers, Tumor
                            
                            
                                This is a "connection" page, showing publications  Bette  Caan  has written about  Biomarkers, Tumor.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            1.319
         
        
        
     
 
    
        
        - 
            Intrinsic subtypes from PAM50 gene expression assay in a population-based breast cancer cohort: differences by age, race, and tumor characteristics. Cancer Epidemiol Biomarkers Prev. 2014 May; 23(5):714-24.
            
            
                Score: 0.409
            
         
        
        - 
            Intrinsic subtypes from the PAM50 gene expression assay in a population-based breast cancer survivor cohort: prognostication of short- and long-term outcomes. Cancer Epidemiol Biomarkers Prev. 2014 May; 23(5):725-34.
            
            
                Score: 0.409
            
         
        
        - 
            Variation in the FGFR2 gene and the effects of postmenopausal hormone therapy on invasive breast cancer. Cancer Epidemiol Biomarkers Prev. 2009 Nov; 18(11):3079-85.
            
            
                Score: 0.076
            
         
        
        - 
            Tumor markers and rectal cancer: support for an inflammation-related pathway. Int J Cancer. 2009 Oct 01; 125(7):1698-704.
            
            
                Score: 0.076
            
         
        
        - 
            Biomarker-calibrated energy and protein consumption and increased cancer risk among postmenopausal women. Am J Epidemiol. 2009 Apr 15; 169(8):977-89.
            
            
                Score: 0.073
            
         
        
        - 
            Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population. J Natl Cancer Inst. 2008 Apr 16; 100(8):597-8; author reply 599.
            
            
                Score: 0.068
            
         
        
        - 
            Plasma carotenoids and recurrence-free survival in women with a history of breast cancer. J Clin Oncol. 2005 Sep 20; 23(27):6631-8.
            
            
                Score: 0.057
            
         
        
        - 
            Impact of resistance training on inflammatory biomarkers and associations with treatment outcomes in colon cancer. Cancer. 2025 May 01; 131(9):e35865.
            
            
                Score: 0.056
            
         
        
        - 
            Postdiagnosis social networks and breast cancer mortality in the After Breast Cancer Pooling Project. Cancer. 2017 Apr 01; 123(7):1228-1237.
            
            
                Score: 0.031
            
         
        
        - 
            Postdiagnosis supplement use and breast cancer prognosis in the After Breast Cancer Pooling Project. Breast Cancer Res Treat. 2013 Jun; 139(2):529-37.
            
            
                Score: 0.024
            
         
        
        - 
            Glutathione peroxidase tagSNPs: associations with rectal cancer but not with colon cancer. Genes Chromosomes Cancer. 2012 Jun; 51(6):598-605.
            
            
                Score: 0.022
            
         
        
        - 
            A comparison of colon and rectal somatic DNA alterations. Dis Colon Rectum. 2009 Jul; 52(7):1304-11.
            
            
                Score: 0.019